Biotech News
Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
ir.intelliatx.com2026-04-29 11:02 EST
CAMBRIDGE, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced the pricing of an underwritten public offering of